IP Library Granted Patent US 9,846,762
Granted Patent B2
US 9,846,762 · App. 14/012,029 · Granted Dec 19, 2017

Gene signature for the prediction of radiation therapy response

Inventors: Javier F. Torres-Roca (St. Petersburg, FL); Steven Eschrich (Lakeland, FL)
Assignee: University of South Florida
G06F19/12C12Q1/6883G06F19/20G06F19/3437G06F19/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,846,762
App. No.
14/012,029
Granted
Dec 19, 2017
Kind
B2
Abstract

Described are mathematical models and method, e.g., computer-implemented methods, for predicting tumor sensitivity to radiation therapy, which can be used, e.g., for selecting a treatment for a subject who has a tumor.

Claims (12)

1. A method of selecting a treatment regimen for a subject having a solid tumor, the method comprising:

determining expression levels of signature genes comprising Androgen receptor (AR); Jun oncogene (c-Jun); Signal transducer and activator of transcription 1 (STAT1); Protein kinase C, beta (PRKCB or PKC); V-rel reticuloendotheliosis viral oncogene homolog A (avian) (RELA or p65); c-Abl oncogene 1, receptor tyrosine kinase (ABL1 or c-Abl); SMT3 suppressor of mif two 3 homolog 1 ( S. cerevisiae )(SUMO1); PAK2; Histone deacetylase 1 (HDAC1); and Interferon regulatory factor 1 (IRF1) in a cell from the solid tumor;

assigning a radiation sensitivity index to the solid tumor based on expression levels of the signature genes, wherein assigning a radiation sensitivity index comprises applying a rank-based linear regression model to the gene expression levels; and

selecting a dose of radiation that is greater than a preselected dose of radiation for a subject who has a radiation sensitivity index that is above a preselected threshold.

2. The method of claim 1 , wherein the signature genes are weighted.

3. The method of claim 1 , wherein the linear regression model is represented by the following algorithm:

RSI= k 1 *AR+ k 2 *c -jun+ k 3 *STAT1 +k 4 *PKC+ k 5 *Rel A+k 6 *cAbl+k 7 *SUMO1 +k 8 *PAK2 +k 9 *HDAC1 +k 10 *IRF1.   I

4. The method of claim 1 , wherein the method is computer-implemented.

5. The method of claim 1 , wherein the solid tumor originates from a carcinoma of the head and neck, lung, prostate, colon, liver, brain, rectum, ovary, oral cavity, esophagus, cervix, or bone.

6. The method of claim 1 , wherein the method further comprises administering the selected treatment to the subject.

7. The method of claim 1 , wherein the linear regression model is represented by the following algorithm:

RSI=−0.0098009*AR+0.0128283 *c -jun+0.0254552*STAT1−0.0017589*PKC−0.0038171*Rel A+ 0.1070213 *cABL− 0.0002509*SUMO1−0.0092431*PAK2−0.0204469*HDAC1−0.0441683*IRF1.   II

Assignments (4)
CONFIRMATORY LICENSE Recorded Aug 17, 2021
From: H. LEE MOFFITT CANCER CET & RES INST
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 057208/0342 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2014
From: TORRES-ROCA, JAVIER F.; ESCHRICH, STEVEN
To: UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 032539/0403 →
CONFIRMATORY LICENSE Recorded Jan 28, 2014
From: H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE INC.
To: US ARMY, SECRETARY OF THE ARMY
Reel/Frame 032133/0034 →
CONFIRMATORY LICENSE Recorded Sep 12, 2013
From: H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE, INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031207/0746 →
Continuity (7)
Continuation 13037153 · Feb 28, 2011
Continuation 12210135 · Sep 12, 2008
Continuation In Part 12053796 · Mar 24, 2008
Provisional Application 60972544 · Sep 14, 2007
Provisional Application 60896550 · Mar 23, 2007
Provisional Application 60896350 · Mar 22, 2007
Related Publication 20130344169A1 · Dec 26, 2013